The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extracellular (EC) Mucin5AC (MUC5AC) detection after neoadjuvant therapy (NAT) and the risk of recurrence in resected pancreatic ductal adenocarcinoma (R-PDA).
 
Ashish Manne
Honoraria - Onclive
Consulting or Advisory Role - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Cardinal Health
 
Ashwini K. Esnakula
No Relationships to Disclose
 
Ankur Sheel
No Relationships to Disclose
 
Amir Sara
No Relationships to Disclose
 
Kai He
Consulting or Advisory Role - AstraZeneca; BioNTech SE; Bristol-Myers Squibb; Iovance Biotherapeutics; Lyell Immunopharma; Mirati Therapeutics; Obsidian Therapeutics; Perthera
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); Mirati Therapeutics (Inst); Oncoc4 (Inst)
 
Jordan M. Cloyd
Other Relationship - Journal of Gastrointestinal Cancer
 
Anne M. Noonan
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I); Deciphera (I); Eisai; Elevar Therapeutics; Exelixis; GOG Foundation (I); Helsinn Healthcare; Immunogen (I); Merck (I); OncLive/MJH Life Sciences; OncLive/MJH Life Sciences (I); QED Therapeutics; Taiho Pharmaceutical
 
John L. Hays
Consulting or Advisory Role - AADi; AstraZeneca; Clovis Oncology; Deciphera; Immunogen; Ipsen; Merck; Mersana; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Merck; Tesaro
 
Sameek Roychowdhury
Stock and Other Ownership Interests - Johnson & Johnson (I)
Honoraria - Illumina; Integrated DNA Technologies
Consulting or Advisory Role - AbbVie; Incyte; Incyte; Merck; QED Therapeutics; Seagen
Research Funding - Ignyta; Incyte; QED Therapeutics; Takeda
 
Arjun Mittra
Stock and Other Ownership Interests - Lilly
Research Funding - Tempus
 
Pannaga G. Malalur
Honoraria - OncLive/MJH Life Sciences
 
Ning Jin
No Relationships to Disclose
 
Shafia Rahman
No Relationships to Disclose
 
Susan Tsai
No Relationships to Disclose
 
Mary Dillhoff
No Relationships to Disclose
 
Wancai Yang
No Relationships to Disclose
 
Lianbo Yu
No Relationships to Disclose